Meet your new FDA commissioner
DR. NED SHARPLESS, LEFT, HAS THE INDUSTRY-FRIENDLINESS OF A TRUMP APPOINTEE AND THE BASKETBALL-FRIENDLINESS OF AN OBAMA ONE. (NIH)
He's a two-time biotech entrepreneur. He's a believer in big data. And he's committed to pickup basketball.
Dr. Ned Sharpless is slated to take over for Dr. Scott Gottlieb at the helm of the FDA next month, and the former National Cancer Institute director brings an industry-friendliness that calls to mind his popular predecessor.
As STAT's Lev Facher and Kate Sheridan report, Sharpless is a well-regarded cancer doctor and veteran of the research world who hasn't balked at leaving the ivory tower of academia for the commercial world. He co-founded G1 Therapeutics and Sapere Bio, and his NCI entered into a five-year, $215 million partnership with 11 pharma companies to develop cancer immunotherapies.
Read more.
Dr. Ned Sharpless is slated to take over for Dr. Scott Gottlieb at the helm of the FDA next month, and the former National Cancer Institute director brings an industry-friendliness that calls to mind his popular predecessor.
As STAT's Lev Facher and Kate Sheridan report, Sharpless is a well-regarded cancer doctor and veteran of the research world who hasn't balked at leaving the ivory tower of academia for the commercial world. He co-founded G1 Therapeutics and Sapere Bio, and his NCI entered into a five-year, $215 million partnership with 11 pharma companies to develop cancer immunotherapies.
Read more.
No hay comentarios:
Publicar un comentario